Kennedy Ukadike is a Systemic Lupus Erythematosus Research physician affiliated with Renown Health. OpenAlex indexes 20 publications with 250 citations (h-index 9).
Data verified 27 Oct 2026
Overview
Updated 28 Oct 2026
Kennedy C. Ukadike, M.D., is affiliated with Renown Health (Renown Rheumatology, Reno, NV). The public record shows 20 publications with 250 citations (h-index 9), centered on Systemic Lupus Erythematosus Research, Vasculitis and related conditions, Systemic Sclerosis and Related Diseases. It also documents industry payments reported by 8 companies.
- Most recent indexed publication: 2021 · Journal of clinical medicine
- Top research focus: Systemic Lupus Erythematosus Research
- Open Payments reporting from 8 companies
Generated from the cited public record · current as of 28 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 1 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 9.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
We didn't find any investigator roles for this person on ClinicalTrials.gov. Why? →
Industry payments
Updated 28 Oct 2026
8 companies reported payments to CMS in program years 2022–2024. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year20247 payments
- Janssen Biotech, Inc.Program year20241 payment
- Amgen Inc.Program year20241 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
48.3%Folate Analog Metabolic Inhibitor13.9%Methotrexate100%Part D≥37 patientsAntirheumatic Agent9.7%Leflunomide100%Part D≥27 patients+ 6 more classes in this area
Antiparasitic
21.2%Antimalarial21.2%Hydroxychloroquine Sulfate100%Part D≥61 patientsMetabolism & gastrointestinal
16%Corticosteroid12.8%Prednisone100%Part D≥51 patientsAminosalicylate3.1%Sulfasalazine Dr100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 28 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Implications of Endogenous Retroelements in the Etiopathogenesis of Systemic Lupus Erythematosus.
Journal of clinical medicine
Review2021
Most-cited works
by citation count (OpenAlex)- 01
- 02
- 03POMGnT1 gene alterations in a family with neurological abnormalitiesArticle36 citations2004
- 04
- 05
Network
Updated 28 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 28 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →renown.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →renown.org ↗
Editorial & leadership roles
journal and society appointments- Fellow
American College of Rheumatology (FACR)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →renown.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Nitesh Kuhadiya, MD;, MPH
Renown Health
Alexander Ayzengart, MD
Renown Health
Chia-Yang Hsu, MD
Renown Health
David Felson, MD
Boston University
Marc Hochberg, MD
University of Maryland School of Medicine
Philip Mease, MD
Michelle Petri, MD
Johns Hopkins University School of Medicine